274 related articles for article (PubMed ID: 20406865)
1. Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).
Koek MB; Sigurdsson V; van Weelden H; Steegmans PH; Bruijnzeel-Koomen CA; Buskens E
BMJ; 2010 Apr; 340():c1490. PubMed ID: 20406865
[TBL] [Abstract][Full Text] [Related]
2. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).
Koek MB; Buskens E; van Weelden H; Steegmans PH; Bruijnzeel-Koomen CA; Sigurdsson V
BMJ; 2009 May; 338():b1542. PubMed ID: 19423623
[TBL] [Abstract][Full Text] [Related]
3. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
[TBL] [Abstract][Full Text] [Related]
4. UVB phototherapy in an outpatient setting or at home: a pragmatic randomised single-blind trial designed to settle the discussion. The PLUTO study.
Koek MB; Buskens E; Steegmans PH; van Weelden H; Bruijnzeel-Koomen CA; Sigurdsson V
BMC Med Res Methodol; 2006 Aug; 6():39. PubMed ID: 16882343
[TBL] [Abstract][Full Text] [Related]
5. Review of an established UK home phototherapy service 1998-2011: improving access to a cost-effective treatment for chronic skin disease.
Cameron H; Yule S; Dawe RS; Ibbotson SH; Moseley H; Ferguson J
Public Health; 2014 Apr; 128(4):317-24. PubMed ID: 24726005
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].
Vañó-Galván S; Gárate MT; Fleta-Asín B; Hidalgo A; Fernández-Guarino M; Bermejo T; Jaén P
Actas Dermosifiliogr; 2012 Mar; 103(2):127-37. PubMed ID: 22036021
[TBL] [Abstract][Full Text] [Related]
7. Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service.
Cameron H; Yule S; Moseley H; Dawe RS; Ferguson J
Br J Dermatol; 2002 Nov; 147(5):957-65. PubMed ID: 12410707
[TBL] [Abstract][Full Text] [Related]
8. Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study.
Väkevä L; Niemelä S; Lauha M; Pasternack R; Hannuksela-Svahn A; Hjerppe A; Joensuu A; Soronen M; Ylianttila L; Pastila R; Kautiainen H; Snellman E; Grönroos M; Karppinen T
Photodermatol Photoimmunol Photomed; 2019 Sep; 35(5):332-338. PubMed ID: 31063610
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
[TBL] [Abstract][Full Text] [Related]
10. Home phototherapy for psoriasis is cost-effective.
Harv Womens Health Watch; 2010 Jul; 17(11):7. PubMed ID: 20687238
[No Abstract] [Full Text] [Related]
11. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Ramaekers BLT; Wolff RF; Pouwels X; Oosterhoff M; Van Giessen A; Worthy G; Noake C; Armstrong N; Kleijnen J; Joore MA
Pharmacoeconomics; 2018 Aug; 36(8):917-927. PubMed ID: 29480455
[TBL] [Abstract][Full Text] [Related]
12. Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis.
Yelverton CB; Kulkarni AS; Balkrishnan R; Feldman SR
Manag Care Interface; 2006 Jan; 19(1):33-6, 39. PubMed ID: 16453993
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment.
Hartman M; Prins M; Swinkels OQ; Severens JL; De Boo T; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Br J Dermatol; 2002 Sep; 147(3):538-44. PubMed ID: 12207597
[TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
15. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
16. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
[TBL] [Abstract][Full Text] [Related]
17. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of narrowband UVB phototherapy in psoriasis.
Langan SM; Heerey A; Barry M; Barnes L
J Am Acad Dermatol; 2004 Apr; 50(4):623-6. PubMed ID: 15034514
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
Pyne S; Sach TH; Lawrence M; Renz S; Eminton Z; Stuart B; Thomas KS; Francis N; Soulsby I; Thomas K; Permyakova NV; Ridd MJ; Little P; Muller I; Nuttall J; Griffiths G; Layton AM; Santer M
BMJ Open; 2023 Dec; 13(12):e073245. PubMed ID: 38081673
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
